Program Information
Implanted Markers for Radiation Therapy and TG 199 Update
Q Xu1*, S Park2*, Z Wang3*, (1) MD Anderson Cancer Center at Cooper, Mt Laurel, NJ, (2) McLaren-Flint, Flint, MI, (3) Duke University Medical Center, Durham, NC
Presentations
8:30 AM : Real-time Tracking with Implanted Markers - Q Xu, Presenting Author8:50 AM : Application of Implanted Markers in Proton Therapy - S Park, Presenting Author
9:10 AM : TG-199: Implanted Markers for Radiation Treatment Verification - Z Wang, Presenting Author
TH-B-204-0 (Thursday, August 4, 2016) 8:30 AM - 9:30 AM Room: 204
Implanted markers as target surrogates have been widely used for treatment verification, as they provide safe and reliable monitoring of the inter- and intra-fractional target motion. The rapid advancement of technology requires a critical review and recommendation for the usage of implanted surrogates in current field. The symposium, also reporting an update of AAPM TG 199 - Implanted Target Surrogates for Radiation Treatment Verification, will be focusing on all clinical aspects of using the implanted target surrogates for treatment verification and related issues.
A wide variety of markers available in the market will be first reviewed, including radiopaque markers, MRI compatible makers, non-migrating coils, surgical clips and electromagnetic transponders etc. The pros and cons of each kind will be discussed. The clinical applications of implanted surrogates will be presented based on different anatomical sites. For the lung, we will discuss gated treatments and 2D or 3D real-time fiducial tracking techniques. For the prostate, we will be focusing on 2D-3D, 3D-3D matching and electromagnetic transponder based localization techniques. For the liver, we will review techniques when patients are under gating, shallow or free breathing condition. We will review techniques when treating challenging breast cancer as deformation may occur. Finally, we will summarize potential issues related to the usage of implanted target surrogates with TG 199 recommendations. A review of fiducial migration and fiducial derived target rotation in different disease sites will be provided. The issue of target deformation, especially near the diaphragm, and related suggestions will be also presented and discussed.
Learning objectives
1. Knowledge of a wide variety of markers
2. Knowledge of their application for different disease sites
3. Understand of issues related to these applications
Funding Support, Disclosures, and Conflict of Interest: Z. Wang: Research funding support from Brainlab AG Q. Xu: Consultant for Accuray; Q. Xu, I am a consultant for Accuray planning service
Handouts
- 115-31840-387514-119599.pdf (Q Xu)
- 115-31842-387514-118543.pdf (Z Wang)
Contact Email: